The development and application of a quantitative ELISA detection method for enterovirus 71 antigen
10.3760/cma.j.issn.0254-5101.2011.11.017
- VernacularTitle:肠道病毒71抗原ELISA检测方法构建及其应用
- Author:
Jinle HAN
;
Jizong JIA
;
Chuan LI
;
Liang YANG
;
Delei HE
;
Juan LI
;
Pengfei YOU
;
Xiangzhong YE
;
Yimin LI
- Publication Type:Journal Article
- Keywords:
Enterovirus 71;
Double antibody sandwich ELISA;
Specific activity
- From:
Chinese Journal of Microbiology and Immunology
2011;31(11):1031-1034
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo develop an ELISA method for quantitative determination of enterovirus 71 (EV71) antigen.The method can be applied to detect EV71 antigen contents and analyze the correlation between immunogenicity and immunoprotection.It also can be used for tissue culture infective dose( TCID50 ) assay.MethodsA double antibody sandwich ELISA method was developed for quantitative determination of EV71 antigen on the basis of the high-affinity neutralizing monoclonal antibodies ( K8G2 and Y8H2-HRP).This method was compared with microscopic observation for the detection of EV71 TCID50.The correlation was analyzed between the specific activity of EV71 antigen and the EV71 neutralizing antibody titer in immune serum.ResultsThe linear range of this method was 0.125-4.0 U/ml and the R2 value was 0.9911.The reagent did not react with other antigens except EV71 antigen.The recovery ratio of this method was 0.89-1.16.The coefficient of variation was less than 15％.The heat recovery rate was above 85％ when the reagent was in 37℃ for 9 days.There was a good correlation in TCID50 of EV71 between this method and microscopic observation,r=0.990.The specific activity of EV71 antigen had positive correlation with the neutralization titer of immune serum in 21 EV71 strains,r=0.930.ConclusionThe quantitative ELISA method for EV71 antigen was developed,which could be used to detect EV71 antigen contents and analyze TCID50.The specific activity of EV71 antigen detected by the method could be used to evaluate the immunoprotection of the vaccine potency test.
